Projects per year
Fingerprint
Dive into the research topics where Lorna Rodriguez-Rust is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 2 Finished
-
Regulation of MDR1 Expression and Drug Resistance by CD44
Rodriguez-Rust, L. & Rodriguez-Rust, L.
7/1/07 → 5/31/13
Project: Research project
-
FUNCTIONS AND INHIBITION OF HIV POLYMERASE
National Institute of Allergy and Infectious Diseases
5/1/93 → 4/30/99
Project: Research project
-
PIPAC for the Treatment of Gynecologic and Gastrointestinal Peritoneal Metastases: Technical and Logistic Considerations of a Phase 1 Trial
Raoof, M., Malhotra, G., Kohut, A., O’Leary, M., Frankel, P., Tran, T., Fakih, M., Chao, J., Lim, D., Woo, Y., Paz, I. B., Lew, M., Cristea, M. C., Rodriguez-Rodriguez, L., Fong, Y., Blakely, A., Whelan, R., Reymond, M. A., Merchea, A. & Dellinger, T. H., Jan 2022, In: Annals of Surgical Oncology. 29, 1, p. 175-185 11 p.Research output: Contribution to journal › Article › peer-review
3 Scopus citations -
Targeting Fc Receptor-Mediated Effects and the “Don’t Eat Me” Signal with an Oncolytic Virus Expressing an Anti-CD47 Antibody to Treat Metastatic Ovarian Cancer
Tian, L., Xu, B., Teng, K. Y., Song, M., Zhu, Z., Chen, Y., Wang, J., Zhang, J., Feng, M., Kaur, B., Rodriguez, L., Caligiuri, M. A. & Yu, J., Jan 1 2022, In: Clinical Cancer Research. 28, 1, p. 201-214 14 p.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
Durable Response to PD1 Inhibitor Pembrolizumab in a Metastatic, Metaplastic Breast Cancer
Gorshein, E., Matsuda, K., Riedlinger, G., Sokol, L., Rodriguez-Rodriguez, L., Eladoumikdachi, F., Grandhi, M., Ganesan, S., Toppmeyer, D. L., Potdevin, L., Toomey, K., Hirshfield, K. M. & Chan, N., Jun 18 2021, In: Case Reports in Oncology. 14, 2, p. 931-937 7 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
PARP Inhibition Activates STAT3 in Both Tumor and Immune Cells Underlying Therapy Resistance and Immunosuppression In Ovarian Cancer
Martincuks, A., Song, J., Kohut, A., Zhang, C., Li, Y. J., Zhao, Q., Mak, E., Rodriguez-Rodriguez, L., Yu, H. & Cristea, M., Dec 7 2021, In: Frontiers in Oncology. 11, 724104.Research output: Contribution to journal › Article › peer-review
Open Access -
Targeting ca-125 transcription by development of a conditionally replicative adenovirus for ovarian cancer treatment
Yue, E., Yang, G., Yao, Y., Wang, G., Mohanty, A., Fan, F., Zhao, L., Zhang, Y., Mirzapoiazova, T., Walser, T. C., Rodriguez-Rodriguez, L., Fong, Y., Salgia, R. & Wang, E. W., Sep 1 2021, In: Cancers. 13, 17, 4265.Research output: Contribution to journal › Article › peer-review
Open Access